Lunai Bioworks Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.2041
-0.0028 (-1.35%)
Sep 11, 2025, 10:56 AM - Market open
Lunai Bioworks Employees
Lunai Bioworks had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$2,369,248
Market Cap
47.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 25 | 13 | 108.33% |
| Jun 30, 2023 | 12 | -10 | -45.45% |
| Jun 30, 2022 | 22 | 11 | 100.00% |
| Jun 30, 2021 | 11 | 1 | 10.00% |
| Jun 30, 2020 | 10 | 2 | 25.00% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RENB News
- 4 hours ago - Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics - Accesswire
- 2 days ago - Top 3 Health Care Stocks You'll Regret Missing In Q3 - Benzinga
- 2 days ago - Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Accesswire
- 3 days ago - Lunai Bioworks Strengthens European Strategy Through Restructuring - Accesswire
- 7 days ago - Lunai Bioworks Inc. Retains American Defense International - Accesswire
- 15 days ago - Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics - Accesswire
- 4 weeks ago - Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks - Accesswire
- 6 weeks ago - Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector - Accesswire